Table 2

Circulating triglyceride and cholesterol levels at 12 weeks after dietary and UVR interventions

TreatmentDietUVR (kJ/m2)Triglycerides (mmol/L)HDL cholesterol (mmol/L)LDL cholesterol (mmol/L)Total cholesterol (mmol/L)
1HF-D+00.7 ± 0.12.1 ± 0.20.3 ± 0.04.2 ± 0.4
2HF-D+10.6 ± 0.02.0 ± 0.20.2 ± 0.03.8 ± 0.4
3HF-D+40.8 ± 0.12.1 ± 0.10.2 ± 0.04.3 ± 0.2
4LF-D+01.0 ± 0.11.5 ± 0.10.2 ± 0.02.5 ± 0.2
5LF-D+11.2 ± 0.11.8 ± 0.10.2 ± 0.02.9 ± 0.1
6LF-D+41.1 ± 0.31.3 ± 0.20.1 ± 0.02.2 ± 0.3
7HF-D00.9 ± 0.12.1 ± 0.10.4 ± 0.04.3 ± 0.1
8HF-D10.6 ± 0.02.1 ± 0.00.3 ± 0.04.2 ± 0.2
9HF-D40.9 ± 0.11.5 ± 0.2*0.2 ± 0.0*2.6 ± 0.3*
10LF-D01.2 ± 0.11.6 ± 0.30.1 ± 0.02.4 ± 0.4
11LF-D10.9 ± 0.11.4 ± 0.10.1 ± 0.02.0 ± 0.1
12LF-D41.1 ± 0.11.5 ± 0.10.1 ± 0.02.3 ± 0.1
  • n = 4 mice/treatment.

  • *P < 0.05 relative to no UVR and HF-D with data representative of two experiments.